Marked, Lasting Disease Regression and Concomitantly Induced Autoimmune Hemolytic Anemia and Hemophagocytic Lymphohistiocytosis in a Patient With Lung Adenocarcinoma and Autoantibodies Receiving Atezolizumab Plus Chemotherapy: A Case Report

Various immune-related adverse events can frequently occur, which may be life-threatening if programmed death 1 or its ligand is blocked. Here, we report a rare case of concomitant autoimmune hemolytic anemia and hemophagocytic lymphohistiocytosis caused by atezolizumab plus chemotherapy in a patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Endo, Yoshinari, Inoue, Yusuke, Karayama, Masato, Nagata, Yasuyuki, Hozumi, Hironao, Suzuki, Yuzo, Furuhashi, Kazuki, Enomoto, Noriyuki, Fujisawa, Tomoyuki, Nakamura, Yutaro, Inui, Naoki, Suda, Takafumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8718484/
https://www.ncbi.nlm.nih.gov/pubmed/35005655
http://dx.doi.org/10.1016/j.jtocrr.2021.100263

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8718484/
https://www.ncbi.nlm.nih.gov/pubmed/35005655
http://dx.doi.org/10.1016/j.jtocrr.2021.100263

Ejemplares similares